Physicians have new tools for treating chronic total occlusions (CTOs) after Abbott received U.S. Food and Drug Administration (FDA) approval for guidewires and balloon dilation catheters for treatment of CTOs. Abbott is the only company with FDA approvals of its every day products for treatment of CTOs.
